Abstract: Delirium is an acute and fluctuating disturbance in cognition attention and awareness that is often a reflection of abnormal physiological condition of an individual. Delirium is highly prevalent among an older population and is associated with high mortality, poor medical and functional outcomes, and high healthcare cost. Delirium often has iatrogenic triggers, and it has been recognized as a quality indicator of healthcare organizations. Despite its high prevalence and significance, more than 50% of the delirium cases are underrecognized by healthcare professionals and remained untreated. Most patients in inpatient rehabilitation facilities are older adults with multiple risk factors for delirium including operation, intensive care stay, multiple co-morbidities, and impaired mobility. Early detection, intervention, and primary prevention of delirium will allow patients to avoid additional morbidities and reach their maximum functional potential during their rehabilitation stay. After the systematic implementation of delirium screening in our inpatient rehabilitation facility, we found that 10.3% of patients were screened positive for delirium at admission. This review discusses the systematic implementation of screening and intervention for delirium as well as the epidemiology of delirium to increase the awareness and guide clinical practice for clinicians in inpatient rehabilitation facilities. D elirium is an acute decline in cognitive functioning manifested in fluctuating symptoms of inattention, disorganized thinking, and altered level of consciousness.
D
elirium is an acute decline in cognitive functioning manifested in fluctuating symptoms of inattention, disorganized thinking, and altered level of consciousness. 1 Delirium is the leading complication in hospitalized older adults, with prevalence of 18%-64%, depending on the clinical setting. 1 Because delirium is often iatrogenic, delirium serves as an important indicator of healthcare quality for older hospitalized individuals. The Agency for Healthcare Research and Quality National Quality Measures Clearinghouse of the United States includes delirium screening as a measure for healthcare quality and provides the summary of intervention guidelines.
The clinical population in the inpatient rehabilitation facility (IRF) setting is at a high risk for delirium because of multiple predisposing and precipitating factors including older age, immobilization, multiple medications, and postoperative or postintensive care status. 1 Associated with mortality, morbidity, and functional decline, delirium increases healthcare costs 2.5 times with the estimated cost burden of up to US $152 billion annually. 2 A bulk of this cost, more than US $100 billion per year, accrues after the discharge from the acute hospitalization including rehabilitation services, home health care, and skilled nursing facilities. 2, 3 The literature often reports the care burden in postacute care settings combining IRFs and skilled nursing facilities; however, several reports describe the burden specific to IRFs. One study demonstrated that the simultaneous presence of both delirium and dementia doubled mortality at 12 mos after discharge from a postacute rehabilitation facility. 4 Another study found that delirium was present in approximately one third of stroke survivors admitted to a rehabilitation unit and predicted in-hospital death and further institutionalization. 5 Moreover, delirium is associated with prolonged rehabilitation services 6 and an increased risk of in-hospital falls. Despite high prevalence of delirium and its negative impact on the patient outcomes and the cost, the implementation of proper screening and management of delirium in IRFs has been suboptimum. The purpose of this report is to provide an updated review to increase the awareness of delirium, provide implementation strategies of delirium screening, and suggest practical guidance to clinicians in IRF settings.
DEFINITION AND TYPES OF DELIRIUM
Delirium is a clinical diagnosis entirely based on behavioral symptoms, and there are no laboratory or imaging studies that can confirm the diagnosis. Delirium typically reflects the pathophysiological consequences of an acute medical illness or medication effects. Therefore, it should be perceived as a warning sign of potential health issues to clinicians and caregivers at all care settings. The Diagnostic and Statistical Manual of Mental Disorders (""DSM-5) provides this set of diagnostic criteria for delirium: (1) a disturbance in attention (i.e., reduced ability to direct, focus, sustain, and shift attention) and awareness; (2) the disturbance develops for a short period (usually hours to days) and tends to fluctuate during the course of the day; (3) an additional disturbance in cognition (e.g., memory deficit, disorientation, language disturbance, perceptual disturbance); (4) the disturbances in cognition mentioned previously are not better accounted for by a pre-existing, established, or evolving neurocognitive disorder and do not occur in the context of a severely reduced level of arousal such as coma; and (5) there is evidence from the history, physical examination, or laboratory findings that the disturbance is caused by a direct physiologic consequence of a general medical condition, an intoxicating substance, medication use, or multiple etiologies. 7 Other commonly described presentations of delirium include irregular sleep-wake cycle, psychomotor disturbance (hypoactivity or hyperactivity), inappropriate behavior, and emotional lability. The DSM-5 classifies the following three subtypes of delirium: hyperactive, hypoactive, and mixed delirium. Hyperactive delirium is defined by increased motor activity, loss of control, and restlessness. Hypoactive delirium is defined by decreased activity, decreased speech, and reduced awareness. 7 Hypoactive delirium is more common and tends to be more frequently underrecognized than hyperactive delirium. Patients with rapidly fluctuating levels of hyperactivity and hypoactivity are classified as the mixed type. It is important to differentiate the subtypes of delirium because they are associated with different outcomes including mortality. In general, hypoactive delirium is reported to have a relatively poor prognosis compared with hyperactive delirium. The differential association between hypoactive delirium and poor outcomes may be explained by underdetection and underlying medical issues (hypoxia, metabolic disturbance, organ failure). However, among individuals with hip fractures, pure hyperactive delirium showed worse prognosis than hypoactive type possibly due to higher severity and oversedation leading to cascade of adverse events. 8 The inconsistency of outcome in the literature may result from various screening methods, classification of delirium subtypes, and patient populations.
In addition to the three types of delirium, recent research has emphasized subsyndromal delirium defined as the presence of one or more symptoms of delirium, but not meeting the DSM-5 diagnostic criteria for delirium. 9 Subsyndromal delirium has drawn the attention of clinicians because of the high prevalence of 23% among hospitalized older adults, with the same set of risk factors and similarly poor outcomes compared with the DSM-5 defined delirium.
Delirium, dementia, and depression are common mental disturbances among older adults in IRFs. Both dementia and depression are risk factors for delirium, 1 and delirium may be superimposed on the other diagnoses. The inattention and fluctuating course of cognitive disturbance are considered as cardinal features, which distinguish delirium from dementia. Subdural hematoma also commonly occurs among older adults even without reported trauma especially among those on anticoagulation. The characteristics of these diagnoses are summarized in Table 1 . 7 For the patients who present with hallucination and delusions particularly with the history of psychiatric illness, psychosis is to be considered as a differential diagnosis. However, late-life onset of psychiatric illness is rare, and such psychotic symptoms are likely due to medical causes. 10 
EPIDEMIOLOGY OF DELIRIUM
The incidence of delirium varies greatly depending on the care settings and patient population. The highest incidence rates were reported in the intensive care unit and postoperative care settings. One systematic review showed that delirium may persist with 44.7% of patients at discharge from acute care hospital, 32.8%, 25.6%, and 21% at 1, 3, and 6 mos afterward, respectively. 11 In IRFs, delirium present at admission is of relatively great concern to clinicians because of newly developing delirium seems to be less common than acute care hospital. The overall prevalence of delirium in IRFs is reported as approximately 10% to 16.3%, which is consistent with our finding described in the section of implementation of delirium screening. 12, 13 However, the prevalence varies based on the primary diagnosis. Stroke patients have a delirium prevalence of 33% upon admission to an IRF. 5 Eighty-nine percent of patients with stupor or coma after trauma may progress to delirium, which may be seen in an IRF setting. For the population with hip fractures, 41% of the patients develop delirium during acute hospitalization, and 39% of them have persistent delirium upon discharge, 32% after a month postdischarge, and 6% after 6 mos ( Table 2 ).
14 Delirium results from complex interactions among multiple predisposing and precipitating factors (Table 3) . 1, 12 Predisposing factors are unmodifiable and set baseline vulnerability for an individual. Precipitating factors trigger the development of delirium and are often modifiable. Advanced age is the main predisposing factor due to reduced cholinergic reserve in the aging brain and a high prevalence of underlying cognitive impairment with aging. 1, 15 For trauma patients, the delirium risk increases by 10% for 1-yr increase in age among patients older than 50 yrs. 16 Dementia is also a main predisposing factor, and the risk of delirium is three to six times higher among individuals with dementia compared with those without dementia. Medications are the most common cause of reversible delirium, and specific medications that can trigger delirium are listed in Table 4 . Other modifiable risk factors relevant to rehabilitation include prolonged time to ambulate for patients with hip fractures and prolonged days of deep sedation, mechanical ventilation, and physical retrain in trauma patients.
IMPACT OF DELIRIUM ON HEALTHCARE COST
Associated with mortality, morbidity, and functional decline, delirium increases healthcare costs 2.5 times, according to the study by Leslie et al. 2 focused on the US healthcare systems between 1995 and 1998. These authors estimated that the national cost burden of delirium is US $38 to $152 billion annually. The costs after hospital discharge may be even higher now in 2018, given that Americans have a longer life span than decades ago, and many receive healthcare in hospital settings, postacute rehabilitation services, home care, and informal care giving from relatives. In IRFs, patients with delirium stay approximately 6 days longer than those without delirium. 12 The main cost factors during hospitalization are personnel expenditure and increased length of stay. 17 There have been a number of studies reporting that systematic implementation of delirium screening, prevention, and intervention programs can reduce cost, fall risks, and pressure injuries in various care settings. delirium prevention and intervention reduced delirium incidence by 44%, fall rate by 64%, and length of stay by up to 0.33 day, resulting in potential Medicare cost savings of approximately US $16 billion per year. 19 
PATHOPHYSIOLOGY OF DELIRIUM
Although pathophysiology of delirium is not fully elucidated, delirium is understood as a neurobehavioral syndrome caused by an alteration in neurotransmitter synthesis, function, availability, dysregulation of neuronal activity, increased peripheral and systemic inflammatory cytokines, acute stress response, and direct neuronal injury. 15 The most commonly implicated alterations in neurotransmitters are deficiencies in acetylcholine and melatonin availability and excess in dopamine, norepinephrine, and glutamate. Medications (e.g., anticholinergic drugs, antiparkinsonian drugs), inflammation, and acute stress responses can all contribute to disruption of neurotransmission. 15 Peripherally secreted cytokines may trigger exaggerated response from microglia causing severe inflammation in the brain. In addition, trauma, surgery, or infection can lead to systemic inflammation. These proinflammatory cytokines may disrupt neuronal communication or have a direct neurotoxic effect. An increased cortisol level in response to acute illness and direct neuronal injury by metabolic or ischemic insults may also predispose older adults to delirium. 15 In addition to these insults, in stroke survivors, certain focal lesions may increase delirium risk by disrupting large-scale neural networks supporting attention, orientation, and arousal. 20 Unilateral right-brain strokes double the risk of delirium compared with left-sided strokes. 21 The high risk of delirium in this patient population may be related to right brain dominance for spatial attention and action, as suggested by the prevalence of spatial attention disorders after right-brain stroke. 22 Lesions of the frontal and parietal components of the attention network and of the surrounding white matter were found in several studies of delirium. For example, hypoactive delirium is associated with right inferior and middle frontal lesions after stroke, 23 and overall delirium status is linked to right parietal subcortical white matter lesions in patients with hemorrhagic stroke. 24 Considering that attention impairment is one of the prototypical features of delirium, it is not surprising that patients with abnormalities in the attention network are more likely to experience delirium. Similarly, the arousal network, composed of ascending projections from the midbrain nuclei to subcortical structures including basal forebrain and the thalamus, likely plays an important role in delirium. In a functional neuroimaging study of monitoring patients during and after an episode of delirium, delirious patients compared with healthy controls had an acute reversible disruption of functional connectivity between intralaminar thalamic nuclei and the basal forebrain. 25 In the same study, structural integrity, as measured using diffusion tensor imaging, of the thalamus and the basal forebrain was also predictive of postsurgical delirium status. Therefore, lesions in the right frontal, parietal, or subcortical structures may signal patient vulnerability to delirium.
DIAGNOSTIC AND SCREENING TOOLS
The diagnosis of delirium is made based on the medical history, behavioral observation, and cognitive assessment. 15 Patient's history should confirm that there has been a change from the baseline in the cognitive status. It is critical to exclude other neurological diagnoses. Focal neurological deficits should be taken seriously as evidence of a potential acute neurological events. Formal psychiatric consultation and diagnosis based on DSM-5 may serve as a criterion standard, but this approach may not be a practical method of screening for individuals at risk. Considering the multiple predisposing and precipitating factors among patients in IRFs, and cognitive evaluation being one of the key rehabilitation procedures, it is ideal to incorporate a validated screening tool for delirium as a part of the clinical assessment at IRF admission.
There are a number of validated and reliable tools available for delirium screening. The Confusion Assessment Method (CAM) provides a concise diagnostic algorithm widely used in various care settings. 26 The positive diagnosis using the CAM is based on the presence of two essential features (inattention and fluctuating course) in addition to one of the two features (e.g., disorganized thinking or an alerted level of consciousness). 15 Compared with the criterion standard psychiatric consultation, the CAM showed a sensitivity of 94%-100%, a specificity of 90%-95%. 26 Administering the CAM requires specific training, and assessment and scoring instructions are available online. 27 The 3-Minute Diagnostic Interview for Confusion Assessment Method (3D-CAM) includes 22 questions (the last two are optional) with scripted instructions (reference Web site is listed in the addendum, Supplemental Digital Content 1, http://links.lww.com/PHM/A614). The sensitivity, specificity, and interrater agreement of the 3D-CAM are 95%, 94% and 95%, respectively. 28 Other screening tools include a 16-item scale of Delirium Rating Scale, Memorial Delirium Assessment Scale, and Delirium Symptom Interview. Because the severity of delirium is also an important outcome predictor, quantifying the severity is useful to guide clinical management. These scales include CAM-S (Severity) long and short forms, Confusion Rating Scale, Delirium Assessment Scale, and Delirium Rating Scale. The reference for these tools is available on the addendum (Supplemental Digital Content 1, http://links.lww.com/PHM/A614).
IMPLEMENTING DELIRIUM SCREENING IN INPATIENT REHABILITATION FACILITIES Potential Challenges in Implementing Delirium Screening
Many have advocated for routine screening for delirium in IRFs. 29 However, most patients with delirium are undiagnosed, and because they have not been identified, they receive no delirium-specific interventions.
1 A lack of screening may be accounted for by the following reasons: (1) a perceived difficulty using a delirium screening tool or negative beliefs about older people such as assuming that mental confusion is normal in older adults among clinicians; (2) system-level limitations including time constraints in care provision and frequent staff turnover; (3) suboptimal coordination of priorities within the care team leads to suboptimal support by physician and 30 Given the obstacles identified in the literature, we developed a process to implement delirium screening and reported in this article to share our experience in overcoming specific challenges and barriers in an IRF setting. This is a stakeholder-initiated project that intends to change clinicians' behavior for the goals of improving quality of care and improving patients' outcome.
Implementation Process Delirium Care Task Force and Framework of Implementation
The idea of delirium screening was initiated in 2013 from the perspective of quality improvement and the operational need. During an internal quarterly review of quality outcome indicators, our clinical teams identified change in mental status as the leading cause for a patient being transferred to acute care hospitals. Therefore, it became essential for clinical team to identify the reversible causes of mental status change and potentially avoid unnecessary transfer of patients to acute care hospitals. This fact drove the establishment of the Kessler Institute for Rehabilitation's Delirium Care Task Force (the Task Force), consisting of the following five key members: a physiatrist (the Chair of the Task Force, who had expertise in geriatric rehabilitation and neurorehabilitation), the medical director (expertise in patient safety and care quality), a clinical research coordinator (who was an occupational therapist by training), a night-shift nurse manager (a certified rehabilitation nurse), and a rehabilitation science researcher (in brain injury medicine and neurorehabilitation).
The Task Force built three systems, each comprises a specific personnel, based on the Interactive Systems Framework For Quality Implementation (Fig. 1) . 31 The Synthesis & Translation System leads the project through distilling published evidence and developing a context-specific program that can be implemented in the IRF setting. The Delivery System consists of frontline clinicians (nurses, therapists, physicians) who carry out the actual administration of screening tool (i.e., the 3D-CAM) and provide feedback to the Synthesis & Translation System. The Support System provides resources to the other systems to ensure high-quality implementation including administrative support for training of clinicians and tracking the implementation results.
Selecting the Instrument and Establishing the Care Procedure
At the outset, members of the Task Force (i.e., the authors of this article) set the major goal of the project to establish a delirium screening process as part of routine patient care, following the strategic planning and process of implementation of delirium screening (Fig. 2) . As a stakeholder-initiated project, the Task Force engaged frontline clinicians, admitting nurses in particular, in the selection of the screening tool feasible for the IRF. A recent review conducted by De and Wand 32 found that the CAM was the most widely used instrument for delirium screening in mixed inpatient settings. Thus, we attended educational courses and training at the Center of Excellence for Delirium in Aging: Research, Training, and Educational Enhancement program (CEDARTREE) Boston, MA (National Institute for Health, Grant K07AG041835) obtaining the criterion standard FIGURE 1. Three systems of implementing delirium screening.
evaluator status in using the CAM. During the period of our staff training, the 3D-CAM was published, 28 and we transitioned to use the 3D-CAM in January 2015 based on the feedback from nursing staff.
In addition, the Task Force established a procedure for delirium screening and follow-up actions including the following three steps (Fig. 3): (1) All patients would be screened at admission, and the result would be documented by the admitting nurse. (2) Patients with delirium would continue to be screened daily by nurses or therapists until the patients were clear of delirium for two consecutive days or until the attending physician decided that the assessment was no longer necessary, with follow-up delirium assessment results documented in either the daily nursing or therapy notes. (3) Attending physicians would be notified about the delirium screening result, and patient delirium status would be discussed during multidisciplinary team meetings.
Staff Training
The Task Force organized trainings for staff of all disciplines to participate in educational sessions and learn the procedure laid out in Figure 3 . During the 45-to 60-min educational sessions, members of the Task Force and clinician champions lectured on the need for delirium care, facilitated discussions on exemplary cases, and addressed the need of interdisciplinary communication using the existing documentation system (e.g., nursing notes and team meeting records). All training of 3D-CAM administration was performed separately based on the training manual (reference Web site is available in the addendum, Supplemental Digital Content 1, http://links.lww.com/PHM/A614).
Results of the Taskforce's Evaluation of Implementation and Exploration of Delirium
We randomly audited medical records of 424 admissions for 3 months. There was only one admission missing the document of the 3D-CAM and 8 with unscorable 3D-CAM results. The reasons for unscorable 3D-CAM included global aphasia (n = 5), reduced level of consciousness (n = 1), severe agitation (n = 1), and language barrier (n = 1). After excluding 16 readmissions and 8 unscorable cases, we had 399 patients screened for delirium at their first admissions and 41 (10.3%) of 399 were scored 3D-CAM positive for delirium. Patients with brain disorders have higher prevalence of delirium at admission compared with those with orthopedic conditions (17.4% vs. 3.7%). Twenty-one percent of patients with delirium at admission were transferred back to acute care hospitals compared with 6% of individuals without delirium.
Currently, intervention and prevention of delirium are being implemented in the IRF with promising quality outcomes such as reduced rates of transfers to acute care hospitals by approximately 30%. The mainstay of intervention and prevention is elaborated in the next section.
Workup and Intervention for Patients with Delirium
There are number of clinical practice guidelines and recommendations available from the American Geriatrics Society, Agency for Healthcare Research and Quality, British Geriatric Society, and National Institute for Health and Care Excellence (resource Web sites are listed in the addendum, Supplemental Digital Content 1, http://links.lww.com/PHM/A614). The Joint Commission offers Disease-Specific Certification in Geriatric Delirium. These guidelines universally emphasize early screening, a nonpharmacological multicomponent approach, collaboration among the patient, patient's family, and the interprofessional care team. It is strongly recommended that healthcare systems and hospitals should implement formal educational programs, with ongoing formal and informal sessions for healthcare professionals on delirium.
Prevention of medical complications, identifying for the underlying etiologies, and managing delirium symptoms are the main stay of the delirium treatment. 1 Patients with delirium are at risk of further medical complications including aspiration, dehydration, malnutrition, pressure injuries, and falls. Therefore, preventive measures should be implemented to minimize these complications (e.g., oral care, hydration, swallowing evaluation). Use of restraints and bed alarms are discouraged, because they increase the risk of prolonging delirium and precipitating injuries.
Identification of the Underlying Etiologies
Once a patient is given a diagnosis or suspicion of delirium, medical workup for underlying etiologies should be initiated considering the poor outcomes and minimal risk associated with interventions. 1 Patients should be screened for acute metabolic disturbance (e.g., hypoxemia, hypoglycemia, hypercarbia) and acute medical event (e.g., myocardial infarction) if clinically indicated. Patients also need to be evaluated for poor pain relief, constipation, incontinence, and sleep quality. Laboratory testing and neuroimaging should be targeted based on the history and physical examination. The role of neuroimaging is very limited in patients with confusion without other neurological deficits. 33 The guidelines for neuroimaging make specific recommendations against the routine use of computed tomography brain scanning except those with history of recent falls, head injury, fever with suspicion of encephalitis, decreased level of consciousness with no identified etiology, or focal neurological signs.
Because medication is a leading cause of delirium, which can be reversible, prescribers should avoid "deliriant" medications, which may trigger delirium. The list of deliriants is summarized in Table 4 . Our previous study showed that 75% of the patients screened positive for delirium at admission to the IRF were prescribed at least one of the deliriants from acute care hospital, and 50% and 25% were prescribed at least two and three medications, respectively. 34 For patients with postoperative delirium, suboptimal pain control increases the risk of delirium. It is well-known that opioid medications can trigger delirium, yet the evidence for prescribing nonopioid alternatives to reduce delirium is not compelling. 35 A recent case report showed that a lidocaine patch applied locally triggered delirium in older patient admitted to an IRF and delirium was subsequently reversed by discontinuation of the patch. 36 The workup and intervention protocol in our institution were published previously. 36 We found medications, dehydration, and infections as common causes for delirium. Once delirium diagnosis is established, clinicians at our organization first review medications focusing on deliriants and clinical evaluation of dehydration, dysphagia, and silent aspiration pneumonia. The rest of the workup is continued afterward based on clinical suspicion. The reversal of delirium depends on the duration and severity of the symptoms, underlying cognitive impairment, and general health of the patient.
Nonpharmacological Intervention
Nonpharmacological approaches including behavioral intervention are the mainstay of delirium management (Table 5) , including hydration, nonpharmacologic approaches to sleep, creating a quiet and comfortable environment, and providing optimal pain relief. 1 As it was emphasized in clinical practice guidelines (listed in the addendum, Supplemental Digital Content 1, http://links.lww.com/PHM/A614), earning the buy-in from multiple disciplines of healthcare professionals and family members via formal and informal education is prerequisite for successful intervention. Delirium does not only affect patients but also affect their families, who are usually not well informed about the sudden mental change that their loved ones are experiencing. Furthermore, families are usually not well-prepared to cope with the consequences of delirium. 37 Thus, it is crucial that a care procedure for delirium, including patient and family education, is implemented in clinical practices. With proper education about delirium, family members and caregivers often do an excellent job in reorienting patients using familiar items such as family photos or talking about specific upcoming events for the patients and their family. The resources for family education is 
Prevention of Delirium Using Nonpharmacological Approach
Primary prevention for the individuals at risk of developing delirium has shown to be the most effective strategy to minimize delirium in various healthcare settings. 1 The Hospital Elder Life Program is a model of care targeting the modifiable risk factors by orientation, therapeutic activities, early mobilization, vision and hearing protocols, oral volume repletion, and sleep enhancement. The estimated savings in healthcare cost per patient on the Hospital Elder Life Program are approximately US $9000 per year.
1 Despite improving quality of care and cost savings, sustainability of a delirium prevention program can be challenging. Successful implementation depends on gaining support from the leadership and frontline clinicians, creating champions in multiple disciplines, maintaining evidence-based practice, documenting and sharing positive outcomes among stakeholders, and obtaining long-term funding and resources.
Pharmacological Intervention
Currently, there is no medication approved by The Food and Drug Administration for prevention and treatment for delirium. Pharmacologic management should be reserved for patients with severe agitation and threatening substantial harm to self and/or others, if behavioral interventions have failed or are not possible. 1 For these patients, the lowest effective dose of antipsychotics for the shortest duration may be used. Haloperidol is the most widely used and studied agent for its suggested benefit in reducing symptom severity and duration. For hypoactive type of postoperative delirium, use of antipsychotic or benzodiazepine medications is not recommended.
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Future Directions
Delirium is a challenging condition to the healthcare providers as it leads to poor outcomes and increases healthcare costs in the all healthcare settings. Although most patients in IRFs have multiple risk factors of delirium including old age, immobility, high co-morbidities, and brain conditions, the identification, intervention, and prevention of delirium in IRFs are suboptimal. Valid and reliable screening methods and interventions for delirium are available and can be implemented at IRF settings. Implementing a new care procedure requires leadership support for institutional priority, negotiating and developing shared understandings among clinicians about the beliefs, risks, and advantages of the new methods over the old approach. 38 For the sustainability of delirium intervention in IRF settings, future research should include cost-effectiveness examination. In addition, further research is also needed for characterization of patients with delirium of different subtypes, understanding the underlying medical and neural mechanisms of delirium, and investigating the effectiveness of interventions utilizing IRF specific tools (e.g., body supported treadmill training as mobilization tool).
